knowledge -WSS

knowledge

author：Wikipedia 2025-09-06 04:13:01 - browse：419

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： New brain studies show LSD's effects on the brain in full color

WSS

Test for long Covid? Researchers find new clue in blood samples

Why doctors need education on FDA device approval process

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

The tragedy of Johnson & Johnson’s Covid vaccine

hotspot

knowledge

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Francis Collins on trust in science and how Covid communications failed

Wildfire smoke exposes gaps in outdoor worker protections

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why doctors need education on FDA device approval process

Medical records are filled with copy

Test for long Covid? Researchers find new clue in blood samples

Sports medicine is finally prioritizing gender equality

Eli Lilly, Pfizer, and others want in on the online prescription market

knowledge

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

EU regulator recommends expanding Mounjaro approval to obesity

The surgeon had a dilemma only a Nazi medical text could resolve

Hey, doctors: Don't be no

Prosecutors say FTX founder Sam Bankman

How Brent Saunders' Allergan experiment failed

hotspot

entertainment

entertainment

Wikipedia